Brainsway (BRSYF) Total Non-Current Liabilities (2018 - 2025)
Brainsway (BRSYF) reported Total Non-Current Liabilities of $17.5 million for Q4 2025, up 5.26% on a YoY basis from $16.7 million in Q4 2024, and up 924.69% quarter-over-quarter from -$2.1 million in Q3 2025.
Brainsway (BRSYF) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends
Brainsway has reported Total Non-Current Liabilities for 8 years, with the latest figure at $17.5 million in Q4 2025.
- For the quarter ending Q4 2025, Total Non-Current Liabilities rose 5.26% year-over-year to $17.5 million; the trailing twelve-month figure through Dec 2025 stood at $17.5 million (up 5.26% YoY), and the FY2025 full-year result was $17.5 million, up 5.26% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $17.5 million, up from -$2.1 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $17.9 million in Q2 2025, with the low at -$2.1 million in Q1 2025.
- Historically, Total Non-Current Liabilities has averaged $11.4 million across 5 years, with a median of $14.8 million in 2021.
- Annual changes were most pronounced in 2021 — Total Non-Current Liabilities soared 30850.0% — and 2025, when it rose 5.26%.
- Brainsway's Total Non-Current Liabilities stood at $9.3 million in 2021, then rose by 17.12% to $10.9 million in 2022, then rose by 6.32% to $11.6 million in 2023, then soared by 43.22% to $16.7 million in 2024, then climbed by 5.26% to $17.5 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $17.5 million (Q4 2025), -$2.1 million (Q3 2025), and $17.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Brainsway | - | - | 11.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.53 Mn |
| Sep 30, 2025 | -2.13 Mn |
| Jun 30, 2025 | 17.92 Mn |
| Mar 31, 2025 | -2.13 Mn |
| Dec 31, 2024 | 16.66 Mn |
| Dec 31, 2023 | 11.63 Mn |
| Dec 31, 2022 | 10.94 Mn |
| Dec 31, 2021 | 9.34 Mn |
| Sep 30, 2021 | 15.82 Mn |
| Jun 30, 2021 | 14.81 Mn |
| Mar 31, 2021 | 14.76 Mn |
| Dec 31, 2020 | 7.58 Mn |
| Sep 30, 2020 | 7.50 Mn |
| Mar 31, 2020 | -48,000.00 |
| Dec 31, 2019 | 7.80 Mn |
| Sep 30, 2019 | 7.80 Mn |
| Jun 30, 2019 | -113,000.00 |
| Mar 31, 2019 | -153,000.00 |
| Dec 31, 2018 | 8.31 Mn |
| Sep 30, 2018 | -229,000.00 |